Users Online: 263

Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 
     
NEUROLOGICAL DISEASES - ORIGINAL ARTICLES
Year : 2021  |  Volume : 11  |  Issue : 3  |  Page : 249-253

Relationship of Serum Cytokine Profile to Steroid Resistance in Demyelinating Neurologic Illnesses


1 Department of Neurology, Chettinad Academy of Research and Education, Chettinad Hospital and Research Institute (CHRI), Kelambakkam, Chennai, India
2 CSIR-n Institute of Chemical Biology, Kolkata, India
3 Department of Biotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chennai, India
4 Department of Neurosurgery, Chettinad Academy of Research and Education, Chettinad Hospital and Research Institute (CHRI), Kelambakkam, Chennai, India

Correspondence Address:
Devaprasad Markandeyan
Chettinad Academy of Research and Education, Chettinad Hospital and Research Institute (CHRI), Kelambakkam, Chennai 603103
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijnpnd.ijnpnd_23_21

Rights and Permissions

Background and Purpose: Corticosteroids form main stay of treatment of autoimmune neurological diseases. Immunotherapy with Intravenous Immunoglobulin, Plasmapheresis, biological agents like Rituximab, Infliximab, etanarcept are also used for treatment of patients who are resistant to steroid treatment and in severe cases. This study was aimed to elicit the relationship between serum cytokine levels and steroid resistance which is important for early commencement of other medications. Methods: The serum samples of patients who presented with autoimmune neurological diseases were collected and cytokine levels were estimated. The cytokine profile of patients who responded well to steroid treatment was compared with that of steroid nonresponders. Results: The steroid unresponsive group had significantly higher serum Interferon gamma and IL-13 levels than steroid unresponsive group. Conclusion: when patients present with high serum levels of IL-13 and Interferon Gamma they should be considered for prompt escalation of immunomodulatory therapy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed198    
    Printed4    
    Emailed0    
    PDF Downloaded37    
    Comments [Add]    

Recommend this journal